View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
January 19, 2022

IACT Health, LMC Manna, True North merge to form Centricity Research

Centricity Research has more than 40 fully owned and integrated clinical research offices in Canada and the US.

Clinical research companies IACT Health, LMC Manna Research, and True North Clinical Research have joined forces and announced the formation of the integrated research site organisation (IRO) Centricity Research.

In November last year, IACT Health and LMC Manna Research formed a strategic alliance, and this continued with the integration of True North Clinical Research in December. The mergers have resulted in the largest combined research network in North America, according to a press release.

Centricity Research has over 40 fully owned and integrated clinical research offices in the US and Canada with access to more than 1.6 million patients and over 150 active investigators.

The IRO conducts inpatient and outpatient Phase I-IV clinical research in more than 35 therapeutic areas. These areas include infectious disease, endocrinology, neurology, cardiology, dermatology, oncology, vaccines and women’s health, among others.

IACT LMC Manna Research COO Karri Venn said: “Centricity Research is excited to bring more opportunities for clinical research in terms of geography and therapeutic areas to patients throughout North America. 

“Together, we also offer sponsors and CROs multi-site, multi-provincial, and statewide access to clinical research centres and experienced investigators who can perform trials across any therapeutic speciality.”

In December last year, IACT LMC Manna Research integrated with True North Clinical Research substantially extending the services of the organisation in central nervous system (CNS) disorders.

A two-site network of CNS-directed clinical research centres, True North was launched in 2006 to carry out clinical research trials in Alzheimer’s dementia.

It now handles broad-ranging trials for CNS disorders, such as mild cognitive impairment, Huntington’s, depression and attention deficit hyperactivity disorder.

In July last year, LMC Manna Research formed a strategic collaboration with Knowde Group to improve the quality and performance of trials in cannabis and psychedelic research.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena